PCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia

To estimate the cost-effectiveness of sunitinib as first-line treatment for metastatic renal-cell carcinoma (mRCC) from the Colombian health system perspective.

Detalles Bibliográficos
Autores Principales: Prieto, VA, Reyes, JM, Lopez-Cabra, C, Diaz, JA, Urrego-Novoa
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://repository.urosario.edu.co/handle/10336/25997
https://doi.org/10.1016/j.jval.2016.03.1586
id ir-10336-25997
recordtype dspace
spelling ir-10336-259972020-08-06T16:20:25Z PCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia PCN87 Evaluación económica de Sunitinib como tratamiento de primera línea para el carcinoma de células renales metastásico en Colombia Prieto, VA Reyes, JM Lopez-Cabra, C Diaz, JA Urrego-Novoa Public Health and Health Services Medical and Health Sciences Applied Economics Economics To estimate the cost-effectiveness of sunitinib as first-line treatment for metastatic renal-cell carcinoma (mRCC) from the Colombian health system perspective. 2016-05-01 2020-08-06T16:20:25Z info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion ISSN: 1098-3015 EISSN: 1524-4733 https://repository.urosario.edu.co/handle/10336/25997 https://doi.org/10.1016/j.jval.2016.03.1586 eng info:eu-repo/semantics/restrictedAccess application/pdf Elsevier Value in Health
institution EdocUR - Universidad del Rosario
collection DSpace
language Inglés (English)
topic Public Health and Health Services
Medical and Health Sciences
Applied Economics
Economics
spellingShingle Public Health and Health Services
Medical and Health Sciences
Applied Economics
Economics
Prieto, VA
Reyes, JM
Lopez-Cabra, C
Diaz, JA
Urrego-Novoa
PCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia
description To estimate the cost-effectiveness of sunitinib as first-line treatment for metastatic renal-cell carcinoma (mRCC) from the Colombian health system perspective.
format Artículo (Article)
author Prieto, VA
Reyes, JM
Lopez-Cabra, C
Diaz, JA
Urrego-Novoa
author_facet Prieto, VA
Reyes, JM
Lopez-Cabra, C
Diaz, JA
Urrego-Novoa
author_sort Prieto, VA
title PCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia
title_short PCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia
title_full PCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia
title_fullStr PCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia
title_full_unstemmed PCN87 Economic Evaluation of Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia
title_sort pcn87 economic evaluation of sunitinib as first-line treatment for metastatic renal cell carcinoma in colombia
publisher Elsevier
publishDate 2016
url https://repository.urosario.edu.co/handle/10336/25997
https://doi.org/10.1016/j.jval.2016.03.1586
_version_ 1674805755211939840
score 11,392632